These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6218211)

  • 21. Cellular DNA content of T helper, T suppressor and B lymphocytes in SLE.
    Surányi P; Mátyus L; Sonkoly I; Szegedi G
    Clin Exp Immunol; 1984 Oct; 58(1):37-41. PubMed ID: 6236918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells.
    Stohl W; Crow MK; Kunkel HG
    N Engl J Med; 1985 Jun; 312(26):1671-8. PubMed ID: 2582253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Null cell immunoregulation in SLE.
    Stephens HA; Fitzharris P; Knight RA; Snaith ML
    J Clin Lab Immunol; 1985 Oct; 18(2):55-61. PubMed ID: 2934551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
    Hostmann A; Jacobi AM; Mei H; Hiepe F; Dörner T
    Lupus; 2008 Dec; 17(12):1064-9. PubMed ID: 19029273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
    Smolen JS; Siminovitch K; Luger TA; Steinberg AD
    Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.
    Scheinecker C; Bonelli M; Smolen JS
    J Autoimmun; 2010 Nov; 35(3):269-75. PubMed ID: 20638240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte transformation induced by autologous cells.
    Weksler ME; Kuntz MM; Birnbaum G; Innes JB
    Fed Proc; 1978 Aug; 37(10):2370-3. PubMed ID: 79505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances on the mechanisms and genetic aspects of lupus erythematosus.
    Steinberg AD
    Adv Nephrol Necker Hosp; 1985; 14():305-32. PubMed ID: 3156469
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.
    Huber C; Pfister R; Stingl G
    Clin Exp Immunol; 1982 Dec; 50(3):525-33. PubMed ID: 6219834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte function in rheumatic disorders.
    Vaughan JH; Chihara T
    Arch Intern Med; 1975 Oct; 135(10):1324-8. PubMed ID: 1100001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.
    Sekigawa I; Okada T; Noguchi K; Ueda G; Hirose S; Sato H; Shirai T
    J Immunol; 1987 May; 138(9):2890-5. PubMed ID: 2952727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T and B lymphocyte function in patients with lupus nephritis: correlation with renal pathology.
    Balow JE; Tsokos GC
    Clin Nephrol; 1984 Feb; 21(2):93-7. PubMed ID: 6233052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The rapid cytofluorometric indices of lymphocyte functional activity in rheumatoid arthritis and systemic lupus erythematosus].
    Benenson EV; Tsaĭ EG
    Ter Arkh; 1990; 62(5):22-7. PubMed ID: 2144372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The busy life of regulatory T cells in systemic lupus erythematosus.
    La Cava A
    Discov Med; 2009 Jun; 8(40):13-7. PubMed ID: 19772836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
    Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
    Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.